Successful in vivo targeting has been shown with EV display of DNA aptamer (AS1411) that binds nucleolin for breast cancer targeting[201], RNA aptamer that binds EGFR, as well as RNA aptamer binding prostate-specific membrane[202]. This evidence concerns the gene EGFR and breast cancer.